Blog
RSS FeedPosted by Michael Wonder on 28 May 2020
‘Vaccine nationalism’: a new dynamic in the race to quash coronavirus
27 May 2020 - International pursuit for a shot is shifting into a contest of which world power can immunise its ...
Posted by Michael Wonder on 28 May 2020
Painkiller packs cut down to size as opioid crackdown intensifies
27 May 2020 - The drugs have become household names in Australia: oxycodone, codeine, morphine and tramadol. ...
Posted by Michael Wonder on 27 May 2020
COVID-19: UK authorises anti-viral drug remdesivir
26 May 2020 - A drug treatment called remdesivir that appears to shorten recovery time for people with coronavirus is ...
Posted by Michael Wonder on 27 May 2020
Record flu vaccines in 2020 to protect Australians
27 May 2020 - An additional two million flu vaccines will available from this week bringing the total number available in ...
Posted by Michael Wonder on 25 May 2020
Contraceptive pill rationed amid countrywide shortage
24 May 2020 - Hansi Bennett knows what it's like to feel constant pain. ...
Posted by Michael Wonder on 19 May 2020
CEO tapped by Trump to make generic drugs during pandemic has a dicey track record
19 May 2020 - As the chief executive of Phlow, the new company awarded $354 million by the federal government ...
Posted by Michael Wonder on 19 May 2020
UK bulk buys hydroxychloroquine as potential COVID-19 treatment
20 May 2020 - Hydroxychloroquine is being bought in bulk by the UK in case it does turn out to ...
Posted by Michael Wonder on 19 May 2020
Teva Canada secures salbutamol inhalers from its global supply chain to mitigate shortage in Canadian market
19 May 2020 - Teva Canada to be first company to import emergency supply of salbutamol inhalers - providing access to ...
Posted by Michael Wonder on 19 May 2020
Gilead ups its donation of the COVID-19 drug remdesivir for U.S. hospitals
18 May 2020 - Gilead Sciences, the drug company behind the experimental COVID-19 therapy remdesivir, has upped the number of ...
Posted by Michael Wonder on 19 May 2020
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): an unprecedented partnership for unprecedented times
18 May 2020 - It has been more than a century since the world has encountered a pandemic like coronavirus disease ...
Posted by Michael Wonder on 18 May 2020
The coronavirus exposed the US' reliance on India for generic drugs. But that supply chain is ultimately controlled by China
17 May 2020 - Sarah Thebarge, a 41-year-old physician assistant living in San Francisco, takes a pill every day to ...
Posted by Michael Wonder on 14 May 2020
Emergency use authorisation of remdesivir: the need for a transparent distribution process
14 May 2020 - On 4 February 2020, the Secretary of the US Department of Health and Human Services (DHHS) determined ...
Posted by Michael Wonder on 14 May 2020
Coronavirus vaccine could be ready in a year: EU medicine agency
14 May 2020 - A vaccine to counter the new coronavirus could be approved in about a year in an ...
Posted by Michael Wonder on 14 May 2020
Serious shortages substitution notice
14 May 2020 - Where a serious shortages substitution notice has been issued by the Therapeutic Goods Administration and supported ...
Posted by Michael Wonder on 14 May 2020
OIA response: effect of COVID-19 on medicine supply
14 May 2020 - PHARMAC responds to OIA request by releasing a raft of documents. ...